Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on German Health Review.
Human Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare
Ottawa, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The global human combinatorial antibody libraries market size was valued at USD 116.2 million in 2024 and is predicted to hit around USD 189.57 million by 2034, rising at a 5.04% CAGR, a study published by...
Animal Health Market to Hit US$119.4 Billion by 2033, Driven by Rising Zoonotic Disease Prevention & Pet Care Demand
Biologics lead with 30.3% share as vaccines drive preventive care; North America dominates, while Asia-Pacific shows fastest growth. AUSTIN, TX, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the global...
Next-Gen Proteomics Market Size, Trends, Competitive Analysis – Towards Healthcare
Ottawa, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The next-generation proteomics market is witnessing rapid global expansion, with projected revenues reaching into the hundreds of millions between 2025 and 2034. This growth is being driven by rising...
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
First patient enrolled in randomized, placebo-controlled study Bensheim, 24. October 2025 – Neurodegenerative diseases represent one of the biggest challenges of our time. In Germany alone, there are currently around 1.8 million people living with...
Axogen, Inc. Reports Third Quarter 2025 Financial Results
ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial...
Sexual Wellness Market Set to Achieve a Valuation of US$ 32.5 billion, Riding on a 4.7% CAGR by 2033
By distribution channel, the specialty stores segment is projected to witness the highest CAGR of 5.8%, in revenue terms, during the forecast period. WILMINGTON, DE, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- The global sexual...
Pet Wellness Services Market Reach USD 98,528.9 million by 2035, Driven by Preventive Care and Subscription-Based Models
Pet Wellness Services Market is experiencing significant growth driven by rising pet ownership, increased focus on pet health, and expanding service offerings NEWARK, DE, UNITED STATES, October 23, 2025 /EINPresswire.com/ -- The Global Pet...
Hormone Replacement Therapy Market Poised to Reach USD 46.32 Billion by 2034, Growing at 6.68% CAGR: Towards Healthcare Report
Ottawa, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The global hormonal replacement therapy market size was valued at USD 24.26 billion in 2024 and is predicted to hit around USD 46.32 billion by 2034, rising at a 6.68% CAGR, a study published by Towards...
Dr. Germán Newall: 30 Years of Artistry, Innovation, and Confidence in Plastic Surgery
Houston’s award-winning Board Certified Plastic Surgeon Dr. Germán Newall leads global innovation in body contouring, BBL, mommy and menopause makeovers. HOUSTON, TX, UNITED STATES, October 22, 2025 /EINPresswire.com/ -- Dr. Germán Newall: 30...
AI in Personalized Nutrition Market to Reach USD 21.54 Billion by 2034, Growing at a CAGR of 17.9%, Says Towards FnB
Ottawa, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The global AI in personalized nutrition market size stood at USD 4.15 billion in 2024 and is predicted to increase from USD 4.89 billion in 2025 to USD 21.54 billion by 2034, according to a report...
Antibody Therapy Market to Surge to USD 951.24 Billion by 2034 at 13.08% CAGR – Towards Healthcare
Ottawa, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The global antibody therapy market size was valued at USD 278.25 billion in 2024 and is predicted to hit around USD 951.24 billion by 2034, rising at a 13.08% CAGR, a study published by Towards Healthcare...
Business Reporter: Aligning decision making across functions
EPM platforms can break down silos and enable smart collaboration LONDON, UNITED KINGDOM, October 29, 2025 /EINPresswire.com/ -- In an article published on Business Reporter, Nicolas Camerman, CEO of Keyrus EPM Global talks about how Enterprise...
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed by Elevara from Japan’s Teijin Pharma with good tolerability and safety, plus early signs of...
Epigenetic Antibodies Market Grows at 18.04% CAGR by 2034 – Towards Healthcare Report
Ottawa, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The global epigenetic antibodies market size was valued at USD 2.29 billion in 2024 and is predicted to hit around USD 12.01 billion by 2034, rising at a 18.04% CAGR, a study published by Towards...
Green Technology & Sustainability Market Surges to $73.90 billion by 2030 - Dominated by GE (US), Siemens (Germany), SAP (Germany)
Delray Beach, FL, Oct. 22, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the Green Technology & Sustainability Market is poised for substantial expansion, expected to reach a compound annual growth rate (CAGR) of 23.7%. The market,...
Vertu Living Broadens Signature Chair Collection Focused on Ergonomics, Craftsmanship, and Workplace Health
San Francisco, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vertu Living, a brand dedicated to advancing modern workspaces, today announced the expansion of its signature line of ergonomic office chairs, reinforcing its commitment to professional well-being...
Türkiye Sets the Stage in Germany ALZ Group to Host its 14th Expo
Photo: ALZ Group via FL Comms. FRANKFURT, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The 3rd Frankfurt International Health Tourism Expo, organized by ALZ Group, is set to open its doors on October 24–25, 2025, at the Messe Frankfurt Congress...
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective Kv1.3 blocker to safely achieve patient plasma levels suitable...
2025 MUSE Hotel Awards Recognizes Global Category Winners in Hospitality and Design for Season 2
The 2025 MUSE Hotel Awards has officially announced the complete list of hospitality and design winners for Season 2. NEW YORK, NY, UNITED STATES, October 21, 2025 /EINPresswire.com/ -- The 2025 MUSE Hotel Awards has officially announced the...
InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its participation in the Guggenheim Securities...